Gallbladder Cancer Cell-Derived Exosome-Mediated Transfer of Leptin Promotes Cell Invasion and Migration by Modulating STAT3-Mediated M2 Macrophage Polarization
Tumor-associated macrophage (TAM) is a major component of tumor microenvironment (TME) and plays critical role in the progression of cancer metastasis. However, TAM-mediated regulation in gallbladder cancer (GBC) has not been fully characterized. Here, we found that exosomes derived from GBC cell polarized macrophage to M2 phenotype, which then facilitated the invasion and migration of GBC cells. We discovered that leptin was enriched in GBC cell-derived exosomes. Exosomal leptin levels promoted invasion and migration of GBC-SD cells. The inhibition of leptin not only attenuated M2 macrophage of polarization but also inhibited the invasive and migratory ability of GBC cell. In addition, GBC-SD cell-derived exosomal leptin induced M2 polarization of macrophage via activation of STAT3 signal pathway. Taken together, our results suggested that GBC cells secrete exosome-enclosed leptin facilitated cell invasion and migration via polarizing TAM.
Gallbladder cancer (GBC) is the most common biliary tract malignancy. However, the prognosis is poor for GBC. Thus, it is important to understand the underlying mechanism of gallbladder cancer and progression. Tumor-associated macrophage (TAM), which is a major component of tumor microenvironment (TME), plays critical role in the crosstalk between cancer cells and TME. Macrophages are classified into M1 and M2 macrophage. TAM is defined more closely resemble M2-polarized macrophage . Emerging evidence indicated that M2 macrophage is able to enhance cancer progression  and metastasis . Moreover, the presence of M2 macrophages is supposed to be correlated with a poor prognosis for breast cancer , colorectal cancer , and hepatocellular cancer . However, the role of M2-subtype macrophage in the development of GBC has not been fully characterized.
Exosomes are a class of small membrane-bound vesicles secreted by most cells and rich in RNAs, lipids, and proteins . It has been reported that exosome participates in the communication of tumor cell and tumor microenvironment [8, 9]. In turn, exosome is capable of promoting tumorigenesis , tumor growth [11, 12], and cancer malignant behavior [13, 14]. Recently, more efforts have been made to use exosome as diagnostic marker of different cancers [15, 16]. Exosomes are able to deliver content derived from cancer cell to macrophages . Accumulating evidence suggested cancer cell-derived exosomes are closely related to M2-subtype macrophage activation [18, 19]. Thus, the role of GBC cell-derived exosome in M2 macrophage and GBC development warrants further investigation.
Leptin, which is encoded by LEP gene, is considered to be the first discovered adipokine . Leptin is a critical factor in signal transduction such as AMPK [21, 22], PI3K/AKT , ERK1/2 , and STAT3 . In turn, leptin participates in controlling energy balance , metabolism , immune , tumorigenesis , and cancer metastasis . In particular, leptin is involved in macrophage polarization . Recent study indicated that leptin could promote invasion and migration of GBC cells . However, whether leptin transfer in exosomes derived from GBC cells promotes M2 macrophage polarization and enhances GBC cell invasion and migration remains unclear.
In the current study, we demonstrated that leptin is upregulated in GBC cell-derived exosomes and can be delivered to macrophages and promotes M2-subtype macrophages. Activation of M2-subtype macrophages enhances GBC cell invasion and migration. This may provide a new strategy for the treatment of gallbladder cancer.
2. Materials and Methods
2.1. Cell Lines
GBC cell line GBC-SD and human monocyte cell line THP-1 were purchased from Cell Bank of the China Science Academy (Shanghai, China). GBC-SD cell was cultured in DMEM, and THP-1 cell was maintained in RPMI-1640 medium. All of the mediums were supplemented with 10% exosome-depleted fetal bovine serum (Gibco, Thermo Fisher Scientific) and penicillin-streptomycin in a 5% CO2 atmosphere.
2.2. RNA Interference
GBC-SD cell were transfected with leptin siRNA or scramble control siRNA via Lipofectamine 2000 reagent as suggested by the manufacturer (Invitrogen, USA) .
2.3. Exosome Isolation and Identification
Exosome isolation kits (Umibio, China) are for exosome isolation. Cells were cultured in a complementary medium with 10% exosome-depleted FBS and 1% penicillin–streptomycin. After 3 days of culture, the cells were collected and transferred to centrifuge tube. Cells were spun at 3000 g for 10 min. The supernatants were collected and treated with exosome concentration solution for 2 hrs at 2°C. Then, the precipitate was collected to isolate exosomes by ultracentrifugation at 1000×g for 60 min. The exosomes were harvested from resuspended precipitate at 12000×g for 2 min and purified by exosome purification filter. Exosomes were identified with transmission electron microscopy as described previously .
2.4. Macrophage Differentiation 
Monocytic THP-1 cell with phorbol 12-myristate 13-acetate (PMA, Sigma Aldrich, USA) treatment was performed to obtain M0 macrophage. THP-1 cell was cultured in RPMI-1640 with 10% EV-depleted FBS and treated with 100 ng/ml PMA for 24 h. The M0 macrophages were determined by flow cytometry.
2.5. Flow Cytometry
Cells ( cells) were digested by trypsin and then washed with PBS twice. Cells were then stained with antibodies against CD11b for 30 min at 4°C in the dark, then washed twice, and resuspended in 500 μl of phosphate-buffered saline (PBS).
2.6. Cell Treatment
For macrophage treatment, the 100 μg/ml GBC-SD cell-derived exosomes were cocultured with M0 for 24 h macrophages. And the same volume of PBS was added as a control. For GBC-SD cell treatment, the GBC-SD cells were administrated with conditioned-medium of macrophage cocultured for 24 h with exosomes or PBS.
2.7. Invasion and Migration Assay
The invasion and migration abilities of GBC-SD cells were assessed by 24-well cell culture chamber precoated with or without Matrigel basement membrane gel. GBC-SD cells ( in each well) were plated into the upper chambers. And each lower chamber contained exosome-treated macrophages, PBS-treated macrophages, si-control-transfected macrophage, or si-leptin-transfected macrophage. For migration assays, GBC-SD cells incubated at 37°C for 8 h. For invasion assays, the incubation time was 24 h. After incubation, the membranes stained with crystal violet for 15 min at room temperature. The quantification of invasion and migratory cells were realized by Image Pro Plus.
2.8. Western Blot Analysis
Cells and exosomes were lysed with RIPA buffer. Protein samples were separated by 8–15% SDS-PAGE and transferred to PVDF membrane. The blots were probed with antibodies: anti-leptin (1 : 1000; ab3583; Abcam), anti-STAT3 (1 : 1000; 12640; Cell Signaling Technology), anti-p-STAT3 (1 : 1000; 9134; Cell Signaling Technology), anti-GAPDH (1 : 5000; 10494-1-AP; Proteintech).
2.9. Quantitative Real-Time PCR (qRT-PCR)
Following macrophage treatments with exosomes, cell culture media was removed, and cells were washed in PBS. Total RNA was isolated using Trizol reagent (TaKaRa, Japan) according to manufacturer’s protocol. RNA was reversely transcribed to cDNA using reverse transcription kit (T TaKaRa, Japan). Real-time- (RT-) PCR was implemented using iTaq Universal SYBR Green One-step kit (BioRad). The relative mRNA levels were determined by the quantification method. Results were normalized to the endogenous β-actin mRNA. The following primers were used: GAPDH sense 5--CTGGGCTACACTGAGCACC-3, GAPDH antisense 5-AAGTGGTCGTTGAGGGCAATG-3, TGF-β sense 5-GGTACCTGAACCCGTGTTGCT-3, TGF-β antisense 5-TGTTGCTGTATTTCTGGTAACAGCTC-3, IL10 sense 5-GACTTTAAGGGTTACCTGGGTTG-3, IL10 antisense 5-TCACATGCGCCTTGATGTCTG-3, CD163 sense 5-TTTGTCAACTTGAGTCCCTTCAC-3, CD163 antisense 5-TCCCGCTACACTTGTTTTCAC-3, IL-1β sense 5-ATGATGGCTTATTACAGTGGCAA-3, IL-1β antisense 5-GTCGGAGATTCGTAGCTGGA-3, iNOS sense 5–AGGGACAAGCCTACCCCTC-3, iNOS antisense 5–CTCATCTCCCGTCAGTTGGT-3, leptin sense 5–-GGCGTTAAAGCTCTCGTGG-3, leptin antisense 5–GGACGAATAAGGGCCAGTAAAC-3.
2.10. Flow Cytometry Analysis of Macrophage Markers
After treating the macrophages with exosomes, the cells were harvested and blocked with 3% BSA in PBS for 30 minutes and then incubated with CD68 and CD163/CD206 (BD Biosciences; San Jose, USA). The cells were then analyzed by flow cytometry.
2.11. Statistical Analysis
All of the data were presented as the as indicated of at least three independent experiments by Student’s test or one-way ANOVA for between group differences. was considered statistically significant.
3.1. GBC-SD Cell-Derived Exosomes Promote M2 Macrophage Polarization and Subsequently Enhance Cell Invasion and Migration
To determine the role of GBC-SD cell-derived exosomes in M2 macrophage polarization, the exosomes were isolated as described previously. Exosomes derived from GBC-SD cell were identified by electron microscopy (Figure 1(a)). The exosome markers CD9, CD63, and TSG101 were increased in GBC-SD cell-derived exosomes compared with GBC-SD cell (Figure 1(b)).
In order to obtain M0 macrophages, THP-1 cell was treated with phorbol-12-myristate-13-acetate (PMA) for 24 hours as described previously . Based on former research, CD11b was reported to be common markers for the differentiation of monocytes into macrophages , and the CD11b level was detected by flow cytometry to confirm the M0 macrophages acquirement (Figure 1(c)). We next examined the effect of GBC-SD cell-derived exosomes on macrophage polarization. The mRNA and protein expression of M2 macrophage markers (CD163, CD206, IL-10, and TGF-beta) increased after the induced macrophage treated with exo (Figures 1(d) and 1(e)). Flow cytometry results suggested that macrophages induced with exo showed significant higher expression of M2 macrophage-related cell surface marked, namely, CD163 and CD206 (Figure 1(f)). In addition, the mRNA and protein expression of M1 macrophage markers (iNOS and IL-1β) increased after the induced macrophage treated with exo (Figures 1(g) and 1(h)). Thus, our results indicated that GBC-SD cell-derived exosomes are able to promote M2 polarization.
To determine the role of GBC-SD cell-derived exosome-induced M2 polarization in GBC-SD cell invasion and migration, the GBC-SD cells were cocultured with exo-treated macrophage or PBS-treated macrophage. As shown in Figure 1(i), GBC-SD cell incubated with exo-treated macrophages displayed elevated invasive ability and migratory ability compared with GBC-SD cocultured with PBS-treated macrophages. Our study suggested that GBC-SD cell-derived exosomes activate M2 macrophage phenotype and subsequently promote invasion and migration of GBC-SD cells.
3.2. GBC-SD Cell-Derived Exosome-Mediated Transfer of Leptin Promotes M2 Macrophage Polarization
Accumulating evidence showed that leptin is upregulated in GBC cell, and overexpression of leptin promotes cancer cell proliferation . To elucidate the leptin expression in GBC-SD cell-derived exosomes, we detected leptin level by Western blot and qRT-PCR. The results indicated that the protein and mRNA expression of leptin was upregulated in GBC-SD cell-derived exosomes (Figures 2(a) and 2(b)). Moreover, the expression of leptin was increased in GBC-SD cell-derived exosome-treated macrophages compared with PBS-treated macrophages (Figure 2(c)). These results suggested cancer cell-derived exosomes could deliver leptin to macrophage.
We next clarify the role of GBC-SD cell-derived exosome-mediated transfer of leptin in polarization of M2 phenotypic polarization. GBC-SD cells were transfected with si-leptin and si-control. After leptin knockdown in GBC-SD cells, exosomes from GBC-SD cell could no longer enhance leptin expression when cocultured with macrophage (Figure 2(d)). In addition, the mRNA and protein expression of IL-10, TGF-β, and CD163 also decreased in macrophages cocultured with exosomes derived from leptin-knockdown GBC-SD cells (Figures 2(e) and 2(f)). Thus, our results indicated that GBC-SD cell-derived exosome leptin was capable of inducing M2 macrophage polarization.
3.3. M2 Macrophage Induced by Exosomal Promotes Invasion and Migration of GBC-SD Cells through Leptin Transfer
We next examine the effect of leptin expression in macrophages on GBC-SD cell migration and invasion. As shown in Figure 3, the invasion and migration of GBC-SD cell presented significantly reduction in macrophage cultured with exosome derived from leptin deficiency-GBC-SD cells. Therefore, exosome leptin promoted GBC-SD cell invasion and migration via M2 macrophage polarization.
3.4. Exosome-Enclosed Leptin Promotes Macrophage to M2 Subtype via STAT3
A few studies have reported that STAT3 pathway could be regulated by leptin [37, 38]. Moreover, it was reported that STAT3 pathway was accounted for macrophage polarization [39, 40]. To determine whether STAT3 was responsible for exosomal leptin-induced M2 phenotypic polarization, Western blot analysis was performed to detect STAT3 phosphorylation (defined as p-STAT3) level. As shown in Figure 4(a), the expression of p-STAT3 was increased in macrophages treated with GBC-SD cell-derived exosomes. However, when treated macrophages with exosomes derived from leptin-knockdown GBC-SD cells, the expression of p-STAT3 was reduced (Figure 4(b)).
In addition, STAT3 inhibitor stattic  was used to treat cells. Western blot and qRT-PCR assay showed that GBC-SD cell-derived exosome treatment could no longer promote M2 macrophage activation when STAT3 signaling was suppressed by stattic (Figures 4(c) and 4(d)). Flow cytometry also verified this result (Figure 4(e)). Moreover, stattic administration reversed the exosomal leptin-mediated forced invasion and migration abilities of GBC-SD cells (Figure 4(f)). Collectively, these results suggested that the STAT3 signaling pathway was accounted for the activation of GBC-SD cell-derived exosome on M2 macrophage polarization.
Tumor together with surrounding stromal cells and ECM constitute a tumorous niche referred as the TME, which plays vital roles in each step of tumorigenesis. Among them, M2 macrophage could promote cancer cell proliferation, invasiveness, and stemness . Our data showed that exosomes derived from GBC cells promote the polarization of macrophage to M2-subtype.
Exosomes are a kind of information transmitter that can mediate a wide range of signal transduction between a variety of cell types (cancer cells-stromal, cells cancer cells-cancer cells and stromal cells-stromal cells) to ensure proliferation growth and metastasis of tumorigenesis-related processes of tumor cells [43, 44]. Leptin is a key factor in signal transduction and is involved in tumorigenesis and cancer metastasis [29, 30]. In addition, studies have shown that leptin is involved in macrophage polarization . Our study found that leptin is highly expressed in exosomes derived from GBC cells. GBC cell-derived exosome-mediated leptin transfer promotes the polarization of M2 macrophages and enhances GBC cell invasion and migration.
Tumor-derived exosomes induce signal changes in receiving cells and affect their functions . In order to explore the changes in specific signaling pathways corresponding to exosomes derived from GBC cells, the signaling pathways related to the polarization of macrophages were observed. STAT6 participates in the regulation of various physiological functions such as cell growth, differentiation, and apoptosis and is closely related to inflammation, tumors, and immune responses . The activation of STAT3 is essential for the polarization of M2 subtype macrophages . This study found that the STAT3 signaling pathway is responsible for the activation of GBC-SD cell-derived exosomes on M2 macrophage polarization.
Taken together, our study demonstrated that leptin is upregulated in GBC cell-derived exosomes and can be delivered to macrophages and promotes M2-subtype macrophages. Activation of M2-subtype macrophages enhances GBC cell invasion and migration.
No data were used to support this study.
Conflicts of Interest
The authors declare that they have no competing interests.
This work was supported by the Yunnan Basic Research Project (Kunming Medical University Joint Special Project), 2018FE001(-232) and Yunnan Provincial Health and Family Planning Commission Medical Reserve Talent Training Program (H-201604).
F. Xu, W. Q. Cui, Y. Wei et al., “Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling,” Journal of experimental & clinical cancer research : CR, vol. 37, no. 1, p. 207, 2018.View at: Publisher Site | Google Scholar
T. Yamaguchi, S. Fushida, Y. Yamamoto et al., “Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination,” Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 19, no. 4, pp. 1052–1065, 2016.View at: Publisher Site | Google Scholar
Z. Yao, J. Zhang, B. Zhang et al., “Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages,” Pharmacological Research, vol. 133, pp. 121–131, 2018.View at: Publisher Site | Google Scholar
P. Chen, H. Zuo, H. Xiong et al., “Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 3, pp. 580–585, 2017.View at: Publisher Site | Google Scholar
R. Li, R. Zhou, H. Wang et al., “Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer,” Cell Death and Differentiation, vol. 26, no. 11, pp. 2447–2463, 2019.View at: Publisher Site | Google Scholar
H. L. Luo, J. Chen, T. Luo et al., “Downregulation of macrophage-derived T-UCR uc.306 associates with poor prognosis in hepatocellular carcinoma,” Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, vol. 42, no. 4, pp. 1526–1539, 2017.View at: Publisher Site | Google Scholar
B. N. Hannafon, A. L. Gin, Y. F. Xu, M. Bruns, C. L. Calloway, and W. Q. Ding, “Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells, cell communication and signaling,” CCS, vol. 17, p. 13, 2019.View at: Google Scholar
D. Xiao, S. Barry, D. Kmetz et al., “Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment,” Cancer Letters, vol. 376, no. 2, pp. 318–327, 2016.View at: Publisher Site | Google Scholar
I. Li and B. Y. Nabet, “Exosomes in the tumor microenvironment as mediators of cancer therapy resistance,” Molecular Cancer, vol. 18, no. 1, p. 32, 2019.View at: Publisher Site | Google Scholar
L. Zhao, W. Liu, J. Xiao, and B. Cao, “The role of exosomes and "exosomal shuttle microRNA" in tumorigenesis and drug resistance,” Cancer Letters, vol. 356, no. 2, pp. 339–346, 2015.View at: Publisher Site | Google Scholar
D. Guo, Y. Chen, S. Wang et al., “Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6,” Immunology, vol. 154, no. 1, pp. 132–143, 2018.View at: Publisher Site | Google Scholar
M. Xue, W. Chen, A. Xiang et al., “Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1,” Molecular Cancer, vol. 16, p. 143, 2017.View at: Google Scholar
K. Yoshida, M. Tsuda, R. Matsumoto et al., “Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer,” Cancer Science, vol. 110, no. 7, pp. 2119–2132, 2019.View at: Publisher Site | Google Scholar
M. Maierthaler, A. Benner, M. Hoffmeister et al., “Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer,” International Journal of Cancer, vol. 140, pp. 176–187, 2017.View at: Google Scholar
J. Ko, N. Bhagwat, S. S. Yee et al., “Combining machine learning and nanofluidic technology to diagnose pancreatic cancer using exosomes,” ACS Nano, vol. 11, no. 11, pp. 11182–11193, 2017.View at: Publisher Site | Google Scholar
M. Wang, S. Ji, G. Shao et al., “Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients,” Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 20, no. 7, pp. 906–911, 2018.View at: Publisher Site | Google Scholar
C. Liang, L. Jiatao, L. Qingqing et al., “Exosomes from melatonin treated hepatocellularcarcinoma cells alter the immunosupression status through STAT3 pathway in macrophages,” International journal of biological ences, vol. 13, pp. 723–734, 2017.View at: Google Scholar
J. Cai, B. Qiao, N. Gao, N. Lin, and W. He, “Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p,” American Journal of Physiology. Cell Physiology, vol. 316, pp. C731–C740, 2019.View at: Google Scholar
A. Pritchard, S. Tousif, Y. Wang et al., “Lung tumor cell-derived exosomes promote M2 macrophage polarization,” Cell, vol. 9, no. 5, p. 1303, 2020.View at: Publisher Site | Google Scholar
R. Denver, R. Bonett, and G. Boorse, “Evolution of leptin structure and function,” Neuroendocrinology, vol. 94, no. 1, pp. 21–38, 2011.View at: Publisher Site | Google Scholar
J. Luo, J. Qi, W. Wang et al., “Antiobesity effect of flaxseed polysaccharide via inducing satiety due to leptin resistance removal and promoting lipid metabolism through the AMP-activated protein kinase (AMPK) signaling pathway,” Journal of Agricultural and Food Chemistry, vol. 67, no. 25, pp. 7040–7049, 2019.View at: Publisher Site | Google Scholar
P. C. Chen, Y. N. Kryukova, and S. L. Shyng, “Leptin Regulates KATP Channel Trafficking in Pancreatic β-Cells by a Signaling Mechanism Involving AMP-activated Protein Kinase (AMPK) and cAMP-dependent Protein Kinase (PKA),” The Journal of Biological Chemistry, vol. 288, no. 47, pp. 34098–34109, 2013.View at: Publisher Site | Google Scholar
X. Gui, H. Chen, H. Cai, L. Sun, and L. Gu, “Leptin promotes pulmonary fibrosis development by inhibiting autophagy via PI3K/Akt/mTOR pathway,” Biochemical and Biophysical Research Communications, vol. 498, no. 3, pp. 660–666, 2018.View at: Publisher Site | Google Scholar
A. Ghasemi, S. I. Hashemy, M. Aghaei, and M. Panjehpour, “Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways,” Journal of Cellular Biochemistry, vol. 119, no. 2, pp. 2333–2344, 2018.View at: Publisher Site | Google Scholar
N. AL Rayyan, J. Zhang, A. S. Burnside, and D. J. Good, “Leptin signaling regulates hypothalamic expression of nescient helix-loop- helix 2 (Nhlh2) through signal transducer and activator 3 (Stat3),” Molecular and Cellular Endocrinology, vol. 384, no. 1-2, pp. 134–142, 2014.View at: Publisher Site | Google Scholar
S. Yu, H. Cheng, M. François et al., “Preoptic leptin signaling modulates energy balance independent of body temperature regulation,” eLife, vol. 7, 2018.View at: Publisher Site | Google Scholar
V. Abella, M. Scotece, J. Conde et al., “Leptin in the interplay of inflammation, metabolism and immune system disorders,” Rheumatology, vol. 13, no. 2, pp. 100–109, 2017.View at: Publisher Site | Google Scholar
C. Procaccini, C. La Rocca, F. Carbone, V. De Rosa, M. Galgani, and G. Matarese, “Leptin as immune mediator: interaction between neuroendocrine and immune system,” Developmental and Comparative Immunology, vol. 66, pp. 120–129, 2017.View at: Publisher Site | Google Scholar
Z. He and G. S. Feng, “Control of body weight versus tumorigenesis by concerted action of leptin and estrogen,” Reviews in Endocrine & Metabolic Disorders, vol. 14, no. 4, pp. 339–345, 2013.View at: Publisher Site | Google Scholar
I. Haque, A. Ghosh, S. Acup et al., “Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway,” BMC Cancer, vol. 18, no. 1, p. 99, 2018.View at: Publisher Site | Google Scholar
L. M. Knowles, D. Kagiri, M. Bernard, E. C. Schwarz, H. Eichler, and J. Pilch, “Macrophage polarization is deregulated in haemophilia,” Thrombosis and Haemostasis, vol. 119, no. 2, pp. 234–245, 2019.View at: Publisher Site | Google Scholar
H. ZOU, Y. LIU, D. WEI et al., “Leptin promotes proliferation and metastasis of human gallbladder cancer through OB-Rb leptin receptor,” International Journal of Oncology, vol. 49, no. 1, pp. 197–206, 2016.View at: Publisher Site | Google Scholar
X. J. Zheng, Z. X. Yang, Y. J. Dong et al., “Downregulation of leptin inhibits growth and induces apoptosis of lung cancer cells via the notch and JAK/STAT3 signaling pathways,” Biology open, vol. 5, no. 6, pp. 794–800, 2016.View at: Publisher Site | Google Scholar
C. Théry, S. Amigorena, G. Raposo, and A. Clayton, “Isolation and characterization of exosomes from cell culture supernatants and biological fluids,” Current Protocols in Cell Biology, vol. 30, no. 1, pp. 3–22, 2006.View at: Publisher Site | Google Scholar
F. Lin, H. B. Yin, X. Y. Li, G. M. Zhu, W. Y. He, and X. Gou, “Bladder cancer cell-secreted exosomal miR-21 activates the PI3K/AKT pathway in macrophages to promote cancer progression,” International Journal of Oncology, vol. 56, no. 1, pp. 151–164, 2019.View at: Publisher Site | Google Scholar
L. Zhou, L. H. Shen, L. H. Hu et al., “Retinoid X receptor agonists inhibit phorbol-12-myristate-13-acetate (PMA)-induced differentiation of monocytic THP-1 cells into macrophages,” Molecular and Cellular Biochemistry, vol. 335, no. 1-2, pp. 283–289, 2010.View at: Publisher Site | Google Scholar
L. Gan, Z. Liu, F. Feng et al., “Foxc2 coordinates inflammation and browning of white adipose by leptin-STAT3-PRDM16 signal in mice,” International Journal of Obesity, vol. 42, no. 2018, pp. 252–259, 2005.View at: Google Scholar
S. Hu, D. Cheng, D. Peng, J. Tan, Y. Huang, and C. Chen, “leptin attenuates cerebral ischemic injury in rats by modulating the mitochondrial electron transport chain via the mitochondrial STAT3 pathway,” Brain and Behavior: A Cognitive Neuroscience Perspective, vol. 9, no. 2, article e01200, 2019.View at: Publisher Site | Google Scholar
C. Qin, W. H. Fan, Q. Liu et al., “Fingolimod protects against ischemic white matter damage by modulating microglia toward M2 polarization via STAT3 pathway,” Stroke, vol. 48, no. 12, pp. 3336–3346, 2017.View at: Publisher Site | Google Scholar
X. Mu, W. Shi, Y. Xu et al., “Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer,” Cell Cycle (Georgetown, Texas), vol. 17, no. 4, pp. 428–438, 2018.View at: Publisher Site | Google Scholar
E. A. Rosado-Olivieri, I. I. Aigha, J. H. Kenty, and D. A. Melton, “Identification of a LIF-responsive, replication-competent subpopulation of human β cells,” Cell Metabolism, vol. 31, no. 2, pp. 327–338.e6, 2020.View at: Publisher Site | Google Scholar
Y. Ma, Y. Ren, H. Wen, and C. Cui, “circCOL1A1 promotes the progression of gastric cancer cells through sponging miR-145 to enhance RABL3 expression,” Journal of Immunology Research, vol. 2021, 2021.View at: Google Scholar
X. Chen, J. Zhou, X. Li, X. Wang, Y. Lin, and X. Wang, “Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype,” Cancer Letters, vol. 435, pp. 80–91, 2018.View at: Google Scholar
V. de Araujo Farias, F. O’Valle, S. Serrano-Saenz et al., “Exosomes derived from mesenchymal stem cells enhance radiotherapy-induced cell death in tumor and metastatic tumor foci,” Molecular Cancer, vol. 17, no. 1, p. 122, 2018.View at: Publisher Site | Google Scholar
X. Xiang, Y. Liu, X. Zhuang et al., “TLR2-mediated expansion of MDSCs is dependent on the source of tumor exosomes,” The American Journal of Pathology, vol. 177, no. 4, pp. 1606–1610, 2010.View at: Publisher Site | Google Scholar
T. Zheng, G. Ma, M. Tang, Z. Li, and R. Xu, “IL-8 secreted from M2 macrophages promoted prostate tumorigenesis via STAT3/MALAT1 pathway,” International Journal of Molecular Sciences, vol. 20, 2019.View at: Google Scholar
R. Solís-Martínez, M. Cancino-Marentes, G. Hernández-Flores et al., “Regulation of immunophenotype modulation of monocytes-macrophages from M1 into M2 by prostate cancer cell-culture supernatant via transcription factor STAT3,” Immunology Letters, vol. 196, pp. 140–148, 2018.View at: Publisher Site | Google Scholar